Multi-Stability and Multi-Instability Phenomena in a Mathematical Model of Tumor-Immune-Virus Interactions

Recent advances in virology, gene therapy, and molecular and cell biology have provided insight into the mechanisms through which viruses can boost the anti-tumor immune response, or can infect and directly kill tumor cells. A recent experimental report (Bridle et al. in Molec. Ther. 18(8):1430–1439, 2010) showed that a sequential treatment approach that involves two viruses that carry the same tumor antigen leads to an improved anti-tumor response compared to the effect of each virus alone. In this article, we derive a mathematical model to investigate the anti-tumor effect of two viruses, and their interactions with the immune cells. We discuss the conditions necessary for permanent tumor elimination and, in this context, we stress the importance of investigating the long-term effect of non-linear interactions. In particular, we discuss multi-stability and multi-instability, two complex phenomena that can cause abrupt transitions between different states in biological and physical systems. In the context of cancer immunotherapies, the transitions between a tumor-free and a tumor-present state have so far been associated with the multi-stability phenomenon. Here, we show that multi-instability can also cause the system to switch from one state to the other. In addition, we show that the multi-stability is driven by the immune response, while the multi-instability is driven by the presence of the virus.

[1]  F. Celada,et al.  IFN-Induced Attrition of CD8 T Cells in the Presence or Absence of Cognate Antigen during the Early Stages of Viral Infections1 , 2006, The Journal of Immunology.

[2]  Eleanor Pullenayegum,et al.  Potentiating cancer immunotherapy using an oncolytic virus. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

[3]  J. Harty,et al.  Regulation of antigen-specific CD8+ T cell homeostasis by perforin and interferon-gamma. , 2000, Science.

[4]  J. R. Pomerening,et al.  Uncovering mechanisms of bistability in biological systems. , 2008, Current opinion in biotechnology.

[5]  R. Vile,et al.  Oncolytic immunovirotherapy for melanoma using vesicular stomatitis virus. , 2007, Cancer research.

[6]  Jung-Han Kimn,et al.  Optimization of Virotherapy for Cancer , 2010, Bulletin of mathematical biology.

[7]  H. Atkins,et al.  Targeted inflammation during oncolytic virus therapy severely compromises tumor blood flow. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

[8]  H. Pircher,et al.  Solid tumors “melt” from the inside after successful CD8 T cell attack , 2006, European journal of immunology.

[9]  D. Kirschner,et al.  Modeling immunotherapy of the tumor – immune interaction , 1998, Journal of mathematical biology.

[10]  R. M. Hendry,et al.  Attenuation of Recombinant Vesicular Stomatitis Virus-Human Immunodeficiency Virus Type 1 Vaccine Vectors by Gene Translocations and G Gene Truncation Reduces Neurovirulence and Enhances Immunogenicity in Mice , 2007, Journal of Virology.

[11]  I B Schwartz,et al.  Bi-instability as a precursor to global mixed-mode chaos. , 1999, Physical review. E, Statistical physics, plasmas, fluids, and related interdisciplinary topics.

[12]  Benedetto Piccoli,et al.  Determination of the optimal therapeutic protocols in cancer immunotherapy. , 2007, Mathematical biosciences.

[13]  A. Barr REALLOCATION OF RESOURCES , 1976, The Lancet.

[14]  Ueda,et al.  Safe, explosive, and dangerous bifurcations in dissipative dynamical systems. , 1994, Physical review. E, Statistical physics, plasmas, fluids, and related interdisciplinary topics.

[15]  Iram Gleria,et al.  Periodic solutions and chaos in a non-linear model for the delayed cellular immune response , 2004 .

[16]  L. Perko Differential Equations and Dynamical Systems , 1991 .

[17]  Eduardo Sontag,et al.  Untangling the wires: A strategy to trace functional interactions in signaling and gene networks , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[18]  Mark A. J. Chaplain,et al.  Oscillations and bistability in the dynamics of cytotoxic reactions mediated by the response of immune cells to solid tumours , 2008, Math. Comput. Model..

[19]  Z Bajzer,et al.  Dynamics of multiple myeloma tumor therapy with a recombinant measles virus , 2009, Cancer Gene Therapy.

[20]  W. Tabachnick,et al.  Influence of Nonsystemic Transmission on the Epidemiology of Insect Borne Arboviruses: A Case Study of Vesicular Stomatitis Epidemiology in the Western United States , 2002, Journal of medical entomology.

[21]  D. Turner,et al.  Persistent Antigen Presentation after Acute Vesicular Stomatitis Virus Infection , 2006, Journal of Virology.

[22]  H. Atkins,et al.  Double trouble for tumours: exploiting the tumour microenvironment to enhance anticancer effect of oncolytic viruses. , 2010, Cytokine & growth factor reviews.

[23]  Pejman Rohani,et al.  Dynamics of infectious diseases and pulse vaccination: Teasing apart the embedded resonance effects , 2006 .

[24]  Tilman Brummer,et al.  Feedback regulation of lymphocyte signalling , 2004, Nature Reviews Immunology.

[25]  Simon Wain-Hobson Virus Dynamics: Mathematical Principles of Immunology and Virology , 2001, Nature Medicine.

[26]  F. Allgöwer,et al.  Bistability Analyses of a Caspase Activation Model for Receptor-induced Apoptosis* , 2004, Journal of Biological Chemistry.

[27]  Jianjun Paul Tian,et al.  Glioma virotherapy: effects of innate immune suppression and increased viral replication capacity. , 2006, Cancer research.

[28]  L Billings,et al.  Exciting chaos with noise: unexpected dynamics in epidemic outbreaks , 2002, Journal of mathematical biology.

[29]  J. Boudreau,et al.  Vesicular stomatitis virus as a novel cancer vaccine vector to prime antitumor immunity amenable to rapid boosting with adenovirus. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

[30]  Svetlana Bunimovich-Mendrazitsky,et al.  Mathematical Model of BCG Immunotherapy in Superficial Bladder Cancer , 2007, Bulletin of mathematical biology.

[31]  B. Benacerraf,et al.  Blood clearance of P32-labeled vesicular stomatitis and Newcastle disease viruses by the reticuloendothelial system in mice. , 1960, Journal of immunology.

[32]  Joseph J. Hale,et al.  From Disorder to Order in Marching Locusts , 2006, Science.

[33]  Rustom Antia,et al.  Lineage relationship and protective immunity of memory CD8 T cell subsets , 2003, Nature Immunology.

[34]  D. Earn,et al.  A simple model for complex dynamical transitions in epidemics. , 2000, Science.

[35]  R. Alemany,et al.  Blood clearance rates of adenovirus type 5 in mice. , 2000, The Journal of general virology.

[36]  D. Earn,et al.  Interactions Between the Immune System and Cancer: A Brief Review of Non-spatial Mathematical Models , 2011, Bulletin of mathematical biology.

[37]  I B Schwartz,et al.  Infinite subharmonic bifurcation in an SEIR epidemic model , 1983, Journal of mathematical biology.

[38]  M. L. Martins,et al.  A multiscale mathematical model for oncolytic virotherapy. , 2009, Cancer research.

[39]  Helen M. Byrne,et al.  Macrophage-tumour interactions: in vivo dynamics , 2003 .

[40]  Alan S. Perelson,et al.  Recruitment Times, Proliferation, and Apoptosis Rates during the CD8+ T-Cell Response to Lymphocytic Choriomeningitis Virus , 2001, Journal of Virology.

[41]  Zeljko Bajzer,et al.  Modeling of cancer virotherapy with recombinant measles viruses. , 2008, Journal of theoretical biology.

[42]  B. Spagnolo,et al.  Monitoring noise-resonant effects in cancer growth influenced by external fluctuations and periodic treatment , 2007, 0710.1317.

[43]  P. Marrack,et al.  Homeostasis of the Memory T Cell Pool , 2005, International Archives of Allergy and Immunology.

[44]  L. Wein,et al.  Analysis of a three-way race between tumor growth, a replication-competent virus and an immune response , 2004, Bulletin of mathematical biology.

[45]  A. Weinberg,et al.  4‐1BB and OX40 stimulation enhance CD8 and CD4 T‐cell responses to a DNA prime, poxvirus boost vaccine , 2004, Immunology.

[46]  W Horsthemke,et al.  Bistability in fluctuating environments. Implications in tumor immunology. , 1979, Bulletin of mathematical biology.

[47]  J. Allison,et al.  PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors , 2010, Proceedings of the National Academy of Sciences.

[48]  K. Tanabe,et al.  Viral oncolysis. , 2002, The oncologist.

[49]  G. Dock The Influence Of Complicating Diseases Upon LeukÆmia. , 1904 .

[50]  R. Parks,et al.  Persistence of Transgene Expression Influences CD8+ T-Cell Expansion and Maintenance following Immunization with Recombinant Adenovirus , 2009, Journal of Virology.

[51]  Lawrence M Wein,et al.  Validation and analysis of a mathematical model of a replication-competent oncolytic virus for cancer treatment: implications for virus design and delivery. , 2003, Cancer research.

[52]  H. Pircher,et al.  On the role of antigen in maintaining cytotoxic T-cell memory. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[53]  Dominik Wodarz,et al.  Towards Predictive Computational Models of Oncolytic Virus Therapy: Basis for Experimental Validation and Model Selection , 2009, PloS one.

[54]  J. Libnoch,et al.  Remission of chronic lymphocytic leukemia after smallpox vaccination. , 1978, Archives of internal medicine.

[55]  D L S McElwain,et al.  A history of the study of solid tumour growth: The contribution of mathematical modelling , 2004, Bulletin of mathematical biology.

[56]  M. L. Martins,et al.  Fighting cancer with viruses , 2005 .

[57]  R. M. Hendry,et al.  Immunogenicity of attenuated vesicular stomatitis virus vectors expressing HIV type 1 Env and SIV Gag proteins: comparison of intranasal and intramuscular vaccination routes. , 2004, AIDS research and human retroviruses.

[58]  A. Meshorer,et al.  Involvement of interferon in virus-induced lymphopenia. , 1983, Cellular immunology.

[59]  Susan M. Kaech,et al.  Effector and memory T-cell differentiation: implications for vaccine development. Nat Rev Immunol. , 2002 .

[60]  A. Bluming,et al.  Regression of Burkitt's lymphoma in association with measles infection. , 1971, Lancet.

[61]  Antonio Lanzavecchia,et al.  Central memory and effector memory T cell subsets: function, generation, and maintenance. , 2004, Annual review of immunology.

[62]  D. Wodarz,et al.  Viruses as antitumor weapons: defining conditions for tumor remission. , 2001, Cancer research.

[63]  Hannah H. Chang,et al.  Multistable and multistep dynamics in neutrophil differentiation , 2006, BMC Cell Biology.

[64]  W. Yokoyama,et al.  Mechanisms involved in synergistic anticancer immunity of anti-4-1BB and anti-CD4 therapy. , 2007, Cancer research.